Peptide Hormones: The Body's Chemical Messengers
Peptide Hormone Fundamentals
6,024 cataloged peptide hormones
The HORDB database has cataloged 6,024 entries including 5,729 distinct peptide hormones, making this the largest class of signaling molecules in the human body.
Zhu et al., Scientific Data, 2022
Zhu et al., Scientific Data, 2022
View as imagePeptide hormones are the largest and most diverse class of signaling molecules in the human body. They range in size from just 3 amino acids (thyrotropin-releasing hormone) to 191 amino acids (growth hormone), and they regulate nearly every physiological process: metabolism, growth, reproduction, mood, appetite, blood pressure, and immune function. A 2022 database project cataloged 5,729 distinct peptide hormones across the animal kingdom.[1] Unlike steroid hormones, which are lipid-soluble and can pass through cell membranes, peptide hormones are water-soluble chains of amino acids that must bind to receptors on the cell surface to initiate their effects. This single chemical property determines how they are made, how they signal, how fast they act, and why most of them cannot be taken as pills. This article covers the biology of peptide hormones as a class, from synthesis through signaling to therapeutic applications. For deeper exploration, see our dedicated articles on how peptide hormones are synthesized, GPCR signaling, how they compare to steroid hormones, prohormone processing, and why oral delivery is so difficult.
Key Takeaways
- The HORDB database has cataloged 5,729 distinct peptide hormones, making them the largest class of signaling molecules in animals (Zhu et al., Scientific Data, 2022)
- Peptide hormones range from 3 amino acids (TRH) to 191 amino acids (growth hormone) and act within seconds to minutes by binding surface receptors and triggering second messenger cascades
- Insulin, discovered in 1921, was the first peptide hormone identified and remains one of the most prescribed biological drugs worldwide with over 100 years of clinical use
- GLP-1 receptor agonists generated over $40 billion in global sales in 2024, making the incretin pathway the most commercially successful peptide hormone drug target in history
- Peptide hormones regulate gene expression through mechanisms beyond classical receptor signaling, with evidence that short peptides can directly interact with DNA and influence transcription (Khavinson et al., Molecules, 2021)
- Oral semaglutide (Rybelsus), approved in 2019, was the first peptide hormone successfully delivered as a pill, overcoming the bioavailability barrier that limits most peptide drugs (Lewis et al., Drug Deliv Transl Res, 2022)
What Makes a Hormone a Peptide Hormone?
A peptide hormone is a signaling molecule composed of amino acids linked by peptide bonds, synthesized by ribosomes, and secreted into the bloodstream or local tissue to act on target cells bearing the appropriate receptor. This definition separates peptide hormones from two other major hormone classes: steroid hormones (derived from cholesterol, lipid-soluble, act on intracellular receptors) and amino acid-derived hormones (like thyroid hormones and catecholamines, which are modified single amino acids rather than chains).[1]
The critical biochemical distinction is water solubility. Because peptide hormones are hydrophilic, they dissolve freely in blood plasma without needing carrier proteins (unlike cortisol or testosterone, which travel bound to binding globulins). This means they reach their targets quickly. But water solubility also means they cannot passively cross the lipid bilayer of cell membranes. Every peptide hormone must have a receptor on the cell surface to transduce its signal inside the cell. For a thorough comparison of these two systems, see our article on peptide vs steroid hormones.
Peptide hormones can be further subdivided by size and structure:
- Small peptides (3-30 amino acids): oxytocin (9 aa), vasopressin (9 aa), TRH (3 aa), somatostatin (14 or 28 aa), GnRH (10 aa)
- Intermediate peptides (30-100 amino acids): insulin (51 aa, two chains), glucagon (29 aa), parathyroid hormone (84 aa), calcitonin (32 aa), GLP-1 (30 aa)
- Large peptide/protein hormones (>100 amino acids): growth hormone (191 aa), prolactin (199 aa), erythropoietin (165 aa)
- Glycoprotein hormones: FSH, LH, TSH, hCG (large heterodimers with carbohydrate chains)
How Peptide Hormones Are Made
Every peptide hormone begins as an mRNA transcript that is translated on ribosomes into a larger precursor protein. This precursor typically contains a signal peptide (which directs it to the endoplasmic reticulum), a propeptide region, and one or more bioactive peptide sequences that will eventually be released.
The precursor undergoes several processing steps: the signal peptide is cleaved during translation, the protein folds in the ER, it moves to the Golgi apparatus where prohormone convertases (PC1/3 and PC2) cleave it at specific dibasic amino acid sites, and the mature peptide is packaged into dense-core secretory granules that sit in the cytoplasm until a stimulus triggers exocytosis.[3]
One precursor can yield multiple active peptides. Proopiomelanocortin (POMC), for example, is processed into ACTH, beta-endorphin, alpha-MSH, and several other bioactive fragments depending on which convertases are expressed in the tissue. Proglucagon is cleaved to produce glucagon in pancreatic alpha cells but GLP-1 and GLP-2 in intestinal L cells. This tissue-specific processing is a major source of peptide hormone diversity. For full detail on how this works, see our article on prohormone processing.
Signaling: The Surface Receptor Requirement
Because peptide hormones cannot enter cells, they depend entirely on cell-surface receptors to transmit their message. The binding of a peptide hormone to its receptor triggers intracellular signaling cascades through second messengers. This indirect signaling amplifies the original hormone signal enormously: a single hormone molecule binding one receptor can generate thousands of second messenger molecules inside the cell.[2]
The dominant receptor class for peptide hormones is the G protein-coupled receptor (GPCR) family. GPCRs are seven-transmembrane-domain proteins that, when activated by a peptide ligand, catalyze the exchange of GDP for GTP on intracellular G proteins. Different G protein subtypes then activate different effectors: Gs activates adenylyl cyclase to produce cAMP, Gq activates phospholipase C to produce IP3 and DAG, and Gi inhibits cAMP production.[2]
Examples of peptide hormones signaling through GPCRs include GLP-1 (via GLP-1R, a class B GPCR), parathyroid hormone (via PTH1R), ghrelin (via GHSR1a), oxytocin (via OXTR), and somatostatin (via SSTR1-5).[4] For a full treatment of GPCR signaling mechanics, see our article on G protein-coupled receptors.
Not all peptide hormones use GPCRs. Insulin binds a receptor tyrosine kinase (the insulin receptor), which activates PI3K/Akt and Ras/MAPK pathways through direct phosphorylation rather than G protein intermediaries. Growth hormone binds a cytokine-type receptor that activates JAK/STAT signaling. These alternative receptor classes still require surface binding but use different intracellular amplification mechanisms.
Speed of action
Peptide hormone signaling is fast compared to steroid signaling. A peptide hormone can bind its receptor, generate second messengers, and alter cellular function within seconds to minutes. Steroid hormones, which must enter the cell, bind nuclear receptors, and alter gene transcription, typically take hours to days to produce effects. This speed difference explains why the body uses peptide hormones for rapid responses (insulin lowering blood glucose after a meal, oxytocin triggering uterine contractions, adrenaline-stimulated glucagon release during stress) and steroid hormones for sustained adaptations (cortisol's metabolic reprogramming, estrogen's developmental effects).
Beyond receptors: direct gene regulation
A 2021 systematic review by Khavinson and colleagues found evidence that short peptides (2-10 amino acids) can regulate gene expression through mechanisms that go beyond classical receptor-mediated signaling. Some short peptides appear to interact directly with DNA in the minor groove, influencing transcription factor binding and chromatin remodeling. The review cataloged examples across hundreds of genes and multiple organ systems.[2] This mechanism remains somewhat controversial and less well-established than receptor-mediated signaling, but it suggests that the functional repertoire of peptide hormones may be broader than traditionally assumed.
Major Peptide Hormone Systems
Insulin and glucagon: metabolic control
Insulin, discovered by Banting and Best in 1921, was the first peptide hormone identified and remains arguably the most medically important. It is a 51-amino-acid peptide consisting of two disulfide-linked chains (A and B) produced by pancreatic beta cells. Insulin lowers blood glucose by promoting glucose uptake into muscle and fat cells and suppressing hepatic glucose production. Its counter-regulatory partner, glucagon (29 amino acids, from alpha cells), raises blood glucose by stimulating glycogenolysis and gluconeogenesis. The balance between these two peptides maintains blood glucose within its narrow physiological range.
The incretin system: GLP-1 and GIP
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gut-derived peptide hormones released after eating that potentiate insulin secretion. This "incretin effect" accounts for 50-70% of the insulin response to an oral glucose load, explaining why eating food produces a much larger insulin response than an equivalent intravenous glucose infusion.[9]
GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) have become the most commercially successful peptide hormone drug class in history, with applications spanning type 2 diabetes, obesity, cardiovascular risk reduction, and kidney protection. For coverage of GLP-1's cardiovascular effects, see our article on GLP-1 drugs and heart disease. For its effects on appetite and weight, see GLP-1 and the brain's reward center.
Oxytocin and vasopressin: the neurohypophyseal peptides
Oxytocin and vasopressin (also called antidiuretic hormone, ADH) are both 9-amino-acid peptides that differ by only two amino acids. Despite this near-identical structure, they have vastly different primary functions. Oxytocin stimulates uterine contractions during labor and milk ejection during breastfeeding, and modulates social bonding, trust, and anxiety.[8] Vasopressin regulates water reabsorption in the kidneys (hence "antidiuretic hormone") and is a potent vasoconstrictor at high concentrations. Both are synthesized in the hypothalamus and released from the posterior pituitary, making them classic neuroendocrine peptides. For more on oxytocin's role in social behavior, see oxytocin and breastfeeding.
Ghrelin: the hunger signal
Ghrelin was discovered in 1999 by Kojima and colleagues as the endogenous ligand for the growth hormone secretagogue receptor (GHSR1a). It is a 28-amino-acid peptide produced primarily by gastric fundus cells, and it is the only known circulating peptide hormone that stimulates appetite.[4] Ghrelin levels rise before meals and fall after eating, functioning as a meal-initiation signal. Uniquely among peptide hormones, ghrelin requires post-translational acylation (addition of an octanoyl group to serine-3) for receptor binding, a modification catalyzed by the enzyme GOAT (ghrelin O-acyltransferase). For a detailed exploration of ghrelin biology, see ghrelin: the hunger hormone.
The pituitary peptides: growth hormone, ACTH, and the hypothalamic-pituitary axes
The pituitary gland produces several peptide hormones under hypothalamic control. Growth hormone (191 amino acids) stimulates longitudinal bone growth and protein synthesis. ACTH (39 amino acids, cleaved from POMC) drives cortisol production from the adrenal cortex. FSH and LH (glycoprotein dimers) regulate gonadal function. Prolactin (199 amino acids) stimulates milk production. TSH (glycoprotein dimer) controls thyroid hormone synthesis. Each of these systems is regulated by hypothalamic releasing and inhibiting peptides: GHRH and somatostatin for growth hormone, CRH for ACTH, GnRH for FSH/LH, and TRH for TSH. The hypothalamic-pituitary axes represent the most hierarchically organized peptide hormone signaling networks in the body. For more on growth hormone-releasing peptides, see our articles on hexarelin and MK-677.
Parathyroid hormone and calcitonin: calcium regulation
Parathyroid hormone (PTH, 84 amino acids) and calcitonin (32 amino acids) are the primary peptide regulators of blood calcium. PTH raises calcium by acting on bone, kidneys, and intestine; calcitonin lowers it by inhibiting osteoclast-mediated bone resorption.[10] The pharmacological exploitation of PTH biology has produced two FDA-approved anabolic osteoporosis drugs: teriparatide (PTH 1-34) and abaloparatide (a PTHrP analog). In the landmark Neer 2001 trial, daily teriparatide injections reduced vertebral fractures by 65% in 1,637 postmenopausal women over 21 months.[12] This result demonstrated the anabolic paradox: a hormone that normally dissolves bone can build it when given as brief daily pulses.[11] For full coverage, see our article on parathyroid hormone.
Regulation: How the Body Controls Peptide Hormone Levels
Peptide hormone systems are regulated at multiple levels, from gene transcription to receptor sensitivity, creating layered feedback mechanisms that maintain physiological balance.
Negative feedback
Most peptide hormone axes operate through negative feedback loops. The hormone's downstream effect inhibits further hormone release. Insulin provides a clear example: rising blood glucose stimulates insulin secretion from beta cells, insulin promotes glucose uptake into tissues, blood glucose falls, and the reduced glucose signal diminishes insulin secretion. Growth hormone secretion is regulated by a more complex axis involving hypothalamic GHRH (stimulatory) and somatostatin (inhibitory), with IGF-1 produced in the liver feeding back to suppress both GH and GHRH release.
Pulsatile secretion
Many peptide hormones are secreted in pulses rather than continuously. GnRH pulses from the hypothalamus at approximately 90-minute intervals drive FSH and LH release from the pituitary. Growth hormone is released in surges, with the largest occurring during deep sleep. The pulsatile pattern matters: continuous GnRH exposure paradoxically suppresses FSH and LH (which is why GnRH agonists are used therapeutically to suppress reproductive hormones in endometriosis and prostate cancer), while intermittent PTH builds bone but continuous PTH destroys it.[10]
Receptor regulation
Target cells can adjust their sensitivity to peptide hormones by modulating receptor density. Prolonged exposure to high hormone concentrations typically causes receptor downregulation (internalization and degradation), reducing the cell's responsiveness. This phenomenon, called desensitization or tachyphylaxis, is clinically relevant: patients on continuous GnRH agonist therapy experience initial receptor activation followed by downregulation and functional suppression.
Conversely, cells can upregulate receptors when hormone levels are chronically low, increasing sensitivity to capture whatever limited signal is available. This bidirectional adjustment allows target tissues to maintain appropriate signaling across a wide range of circulating hormone concentrations.
Half-life and clearance
Peptide hormone half-lives vary enormously and shape their biological roles. TRH has a half-life under 5 minutes. Insulin circulates for about 5-6 minutes. PTH lasts approximately 4 minutes. Oxytocin persists for 3-5 minutes. These short half-lives enable rapid on-off signaling. By contrast, some larger peptide hormones have longer half-lives: erythropoietin circulates for 4-13 hours, and hCG has a half-life of 24-36 hours. The engineering of longer half-lives through lipid conjugation (semaglutide), PEGylation (pegfilgrastim), or Fc fusion (dulaglutide) has been central to making peptide drugs practical for weekly or monthly dosing.
Peptide Hormones as Drugs
The therapeutic potential of peptide hormones was recognized from the very beginning of endocrinology. Insulin was the first protein drug, and its clinical deployment in 1922 transformed type 1 diabetes from a death sentence to a manageable condition. Today, peptide hormone-based drugs span dozens of clinical applications.
Successes
Insulin, calcitonin, oxytocin, vasopressin, GnRH agonists and antagonists, somatostatin analogs (octreotide, lanreotide), teriparatide, GLP-1 receptor agonists, and CGRP-targeting antibodies are all approved peptide-based therapeutics. Schally's work demonstrated that analogs of peptide hormones (LH-RH, somatostatin, bombesin) can be conjugated to cytotoxic agents and targeted to tumors expressing the appropriate receptors, opening the field of peptide receptor-targeted chemotherapy.[7]
Peptide hormones also play roles beyond classical endocrinology. Luhder and Gold (2009) reviewed evidence that short peptide hormones including corticotropin-releasing hormone (CRH), urocortin, alpha-MSH, ghrelin, and cortistatin modulate immune cell function and inflammation, with therapeutic implications for autoimmune diseases like multiple sclerosis and rheumatoid arthritis.[6]
The oral delivery challenge
The water solubility that makes peptide hormones effective signaling molecules also makes them extremely difficult to deliver as oral drugs. In the gastrointestinal tract, peptides face enzymatic degradation by pepsin, trypsin, and chymotrypsin, acidic denaturation in the stomach, and poor absorption across the intestinal epithelium due to their large size and hydrophilicity. Oral bioavailability of unformulated peptides is typically below 1-2%.[5]
The approval of oral semaglutide (Rybelsus) in 2019 represented a landmark in peptide drug delivery. The formulation uses sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), an absorption enhancer that locally raises stomach pH and promotes transcellular absorption of semaglutide across the gastric epithelium. Even with this technology, oral bioavailability remains approximately 1%, requiring patients to take the tablet on an empty stomach with a small amount of water and wait 30 minutes before eating.[5] For detailed coverage of oral peptide delivery challenges, see our article on why peptide hormones can't be taken as pills.
Developmental roles
Peptide hormones are not limited to adult physiology. Sanders (2008) reviewed evidence that insulin, IGF-1, growth hormone, GnRH, and other peptide hormones are synthesized in developing embryonic tissues long before the endocrine glands that produce them in adults have formed. In these contexts, they function as local growth and differentiation factors rather than circulating hormones, influencing cell proliferation, migration, and organogenesis.[3] This dual role, endocrine in adults and paracrine/autocrine in embryos, adds another layer of complexity to peptide hormone biology.
Peptide Hormones Beyond Classical Endocrinology
The traditional view of peptide hormones as endocrine signals traveling through the bloodstream from gland to distant target organ is incomplete. Many peptide hormones function in multiple modes simultaneously.
Paracrine and autocrine signaling
Numerous peptide hormones act locally on neighboring cells (paracrine) or on the cells that produce them (autocrine). Somatostatin, produced by pancreatic delta cells, acts on adjacent alpha and beta cells to suppress both glucagon and insulin secretion. PTHrP functions almost entirely as a paracrine factor in normal physiology, regulating cartilage growth and smooth muscle tone in the tissues where it is produced, despite being structurally related to the endocrine hormone PTH.[10]
Neuropeptides: hormones in the brain
Many peptide hormones serve double duty as neuropeptides, acting as neurotransmitters or neuromodulators in the central and peripheral nervous systems. Oxytocin, vasopressin, CRH, NPY, substance P, CGRP, CCK, and VIP all function both as circulating hormones and as neural signaling molecules. The gut-brain axis depends heavily on peptide signals: GLP-1, PYY, CCK, and ghrelin produced by enteroendocrine cells in the gut communicate nutritional status to the brainstem and hypothalamus through both vagal afferents and circulating peptides.[9]
Immune system peptides
The immune system both produces and responds to peptide hormones. Immune cells express receptors for insulin, growth hormone, CRH, alpha-MSH, and vasoactive intestinal peptide, and some of these peptides directly modulate inflammatory responses. Conversely, activated immune cells can produce peptide hormones including POMC-derived peptides and CRH, creating local regulatory circuits at sites of inflammation.[6] This bidirectional communication between the endocrine and immune systems, sometimes called the "neuroendocrine-immune interface," is an active area of investigation with implications for autoimmune diseases, chronic inflammation, and stress-related disorders.
Evidence Limitations
Our understanding of peptide hormone biology is extensive but far from complete. The HORDB database catalogs 5,729 peptide hormones, but many lack well-characterized receptors, signaling pathways, or physiological roles.[1] The claim that short peptides directly regulate gene expression independently of receptors is supported by experimental data but lacks a fully defined molecular mechanism.[2]
Most peptide hormone research has been conducted in rodent models or cell lines, and translation to human physiology is not always straightforward. Receptor expression patterns, circulating half-lives, and metabolic context differ across species.
The oral delivery problem remains largely unsolved despite the oral semaglutide breakthrough. The SNAC-based formulation works for semaglutide partly because the drug is extraordinarily potent, requiring very low systemic levels for efficacy. Most peptide hormones would need much higher bioavailability than 1% to be therapeutically useful orally.[5]
The Bottom Line
Peptide hormones are water-soluble amino acid chains that serve as the body's primary rapid-signaling system, with over 5,700 distinct peptides cataloged to date. They act by binding surface receptors (primarily GPCRs) and triggering second messenger cascades, producing effects within seconds to minutes. From insulin's discovery in 1921 to the GLP-1 receptor agonist revolution of the 2020s, peptide hormones have been both fundamental biology and transformative medicine. Their water solubility, which makes them effective signals, also makes oral delivery extraordinarily challenging, a barrier only partially overcome by the 2019 approval of oral semaglutide.